![Jean-Sébastien Cleiftie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Sébastien Cleiftie
Directeur/Membre du Conseil chez BioVex, Inc.
Postes actifs de Jean-Sébastien Cleiftie
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioVex, Inc.
![]() BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jean-Sébastien Cleiftie
Anciens postes connus de Jean-Sébastien Cleiftie
Sociétés | Poste | Début | Fin |
---|---|---|---|
ERYTech Pharma SA
![]() ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Corporate Officer/Principal | 27/10/2016 | 01/11/2021 |
SANOFI | Corporate Officer/Principal | 01/10/2010 | 01/08/2016 |
BioVex Group, Inc.
![]() BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Directeur/Membre du Conseil | 15/10/2009 | 24/01/2013 |
PC Associés SAS
![]() PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Analyste en capital-investissement | 01/01/2004 | 01/12/2010 |
Innoven Partners
![]() Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Corporate Officer/Principal | 01/02/2004 | 01/10/2010 |
BioVex Ltd.
![]() BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - | 31/08/2010 |
KIORA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - | - |
Formation de Jean-Sébastien Cleiftie
Cornell University | Masters Business Admin |
Statistiques
Internationale
France | 6 |
Etats-Unis | 5 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Private Equity Analyst | 1 |
Sectorielle
Health Technology | 6 |
Finance | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
SANOFI | Health Technology |
Entreprise privées | 7 |
---|---|
PC Associés SAS
![]() PC Associés SAS Investment ManagersFinance IPSA SA (IPSA), a subsidiary of ACG SA, is a venture capital firm headquartered in Paris. Formerly known as Innoven Partenaires SA, the firm was founded in 1997. | Finance |
BioVex, Inc.
![]() BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Ltd.
![]() BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
![]() BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
ERYTech Pharma SA
![]() ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Innoven Partners
![]() Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Finance |
Université de Paris 5 René Descartes | Consumer Services |
- Bourse
- Insiders
- Jean-Sébastien Cleiftie
- Expérience